AzTrials
AzTrials

Dentin SensitivityNCT02919202

Clinical Trial to Compare the Efficacy of a Fluoride Gel and a Dental Bonding Agent in Treatment of Tooth Sensitivity

A study testing Colgate Fluoride Varnish Suspension. 2.26% Sodium Fluoride. and Self-etching Dentine Bonding Agent in people with Dentin Sensitivity, run by University of Kent at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study compares the efficacy of two dental interventions in the treatment of cervical dentine sensitivity. The participants will be selected from adult dental patients registered at a general dental practice in West Sussex, UK. The participants will be split into 2 groups. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Dentin Sensitivity
What is being tested?
Colgate Fluoride Varnish Suspension. 2.26% Sodium Fluoride. and Self-etching Dentine Bonding Agent
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteUnited Kingdom
Study dates
26 Oct 2016to 4 Jan 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Aged 18-60.
  • Exhibiting CDS elicited by the two test stimuli in relation at least one tooth.

Who cannot join

  • Patients who have undergone comprehensive periodontal treatment in the past 3 months.
  • Patients under the age of 18 or unable to provide valid consent.
  • Teeth that have visible fracture lines, caries, crowns or have been endodontically treated.
  • Patients taking analgesic medication for any systemic conditions.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Carfax Dental Practice

    Horsham, West Sussex, RH12 1EB

Other trials in United Kingdom

About this study

Official title: A Randomised Controlled Trial Investigating a Comparison of Fluoride Varnish vs Self-Etching Dentine Bonding Agent in the Reduction of Cervical Dentine Sensitivity in Patients Attending a General Dental Practice in West Sussex, UK.

This study compares the efficacy of two dental interventions in the treatment of cervical dentine sensitivity. The participants will be selected from adult dental patients registered at a general dental practice in West Sussex, UK. The participants will be split into 2 groups. One group will receive the intervention of topical fluoride varnish application while the other group will receive a topical application of self-etching dentine bonding agent.

Read the detailed description

Topical Fluoride Varnish(TFV) and Self-Etching Dentine Bonding Agent (SEDBA) are both routinely used in dentistry in the management of cervical dentine sensitivity(CDS). Both interventions are topically applied and well tolerated by patients. The interventions differ in mechanism of action. TFV releases fluoride which is incorporated into the organic matrix of dentine making the dentine tubules less conductive. Dentinal tubules form the key conduit between stimulus and pain perception in the tooth. SEDBA differs in that it penetrates and occludes the tubules. It is light cured for an almost instant set time.

Being tested
Colgate Fluoride Varnish Suspension. 2.26% Sodium Fluoride., Self-etching Dentine Bonding Agent
Medical subject headings
Dentin Sensitivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Colgate Fluoride Varnish Suspension. 2.26% Sodium Fluoride.Procedure or surgery

    Also called Duraphat Varnish

    Topical application to exposed dentine on one occasion.

  • Self-etching Dentine Bonding AgentProcedure or surgery

    Also called Scotchbond Universal

    Topical application to exposed dentine on one occasion followed by light-curing procedure.

Study groups in NCT02919202
Study groupRoleWhat they receive
Fluoride VarnishExperimentalColgate Fluoride Varnish Suspension. 2.26% Sodium Fluoride.
Receives: Procedure: Colgate Fluoride Varnish Suspension. 2.26% Sodium Fluoride.
SEDBAActive comparatorSelf-etching Dentine Bonding Agent. Scotchbond Universal by 3M ESPE. Topical application followed by light curing for 20 seconds.
Receives: Procedure: Self-etching Dentine Bonding Agent

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analogue Scale

    to measure pain/sensitivity perception

    Measured: 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Sep 2016 (estimated)
  2. Study start26 Oct 2016
  3. Primary completion4 Jan 2017
  4. Study completion4 Jan 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02919202
Sponsor's protocol ID
ResGov 354
Status last verified
May 2017
First submitted
27 Sep 2016
Last updated
5 May 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Colgate Fluoride Varnish Suspension. 2.26% Sodium Fluoride. and Self-etching Dentine Bonding Agent in people with Dentin Sensitivity, run by University of Kent at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 May 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analogue Scale (time frame: 14 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in